MiR-34a promotes Fas-mediated cartilage endplate chondrocyte apoptosis by targeting Bcl-2

被引:0
|
作者
Huajiang Chen
Jianxi Wang
Bo Hu
Xiaodong Wu
Yu Chen
Renhu Li
Wen Yuan
机构
[1] Second Military Medical University,Department of Spinal Surgery, Changzheng Hospital
来源
Molecular and Cellular Biochemistry | 2015年 / 406卷
关键词
miR-34a; Cartilage endplate chondrocyte; Apoptosis; Bcl-2; Fas;
D O I
暂无
中图分类号
学科分类号
摘要
Apoptosis of cartilage endplate (CEP) chondrocytes is associated with the pathogenesis of intervertebral disk degeneration (IDD). Recent studies have shown that miR-34a is crucially involved in chondrocyte apoptosis during osteoarthritic cartilage. Here, we investigated the involvement of miR-34a in CEP chondrocyte apoptosis in IDD. In human degenerated CEP chondrocytes, miRNA (miR)-34a was markedly elevated in association with increased apoptosis. Bioinformatics target prediction identified Bcl-2 as a putative target of miR-34a. Furthermore, miR-34a inhibited Bcl-2 expression by directly targeting their 3′-untranslated regions, and this inhibition was abolished by mutation of the miR-34a binding sites. In vitro, knockdown of miR-34a in human endplate chondrocytes resulted in overexpression of Bcl-2, whereas upregulation of miR-34a led to repression of Bcl-2. Fas-mediated apoptosis was decreased when antagonizing miR-34a with locked nucleotide analog-miR-34a in human endplate chondrocytes. Taken together, our results demonstrate that upregulated miR-34a potentiates Fas-mediated endplate chondrocyte apoptosis, which is associated with IDD.
引用
收藏
页码:21 / 30
页数:9
相关论文
共 50 条
  • [21] Maternal folic acid deficiency stimulates neural cell apoptosis via miR-34a associated with Bcl-2 in the rat foetal brain
    Li, Wen
    Li, Zhenshu
    Zhou, Dezheng
    Zhang, Xumei
    Yan, Jing
    Huang, Guowei
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2019, 72 : 6 - 12
  • [22] Sensitivity to Fas-mediated apoptosis in pediatric acute lymphoblastic leukemia is associated with a mutant p53 phenotype and absence of Bcl-2 expression
    M Zhou
    L Gu
    AM Yeager
    HW Findley
    Leukemia, 1998, 12 : 1756 - 1763
  • [23] Sensitivity to Fas-mediated apoptosis in pediatric acute lymphoblastic leukemia is associated with a mutant p53 phenotype and absence of Bcl-2 expression
    Zhou, M
    Gu, L
    Yeager, AM
    Findley, HW
    LEUKEMIA, 1998, 12 (11) : 1756 - 1763
  • [24] MiR-136 promotes apoptosis of glioma cells by targeting AEG-1 and Bcl-2
    Yang, Yi
    Wu, Jueheng
    Guan, Hongyu
    Cai, Junchao
    Fang, Lishan
    Li, Jun
    Li, Mengfeng
    FEBS LETTERS, 2012, 586 (20) : 3608 - 3612
  • [25] Hypoxia-inducible factor-2α regulates Fas-mediated chondrocyte apoptosis during osteoarthritic cartilage destruction
    J-H Ryu
    Y Shin
    Y H Huh
    S Yang
    C-H Chun
    J-S Chun
    Cell Death & Differentiation, 2012, 19 : 440 - 450
  • [26] Hypoxia-inducible factor-2α regulates Fas-mediated chondrocyte apoptosis during osteoarthritic cartilage destruction
    Ryu, J-H
    Shin, Y.
    Huh, Y. H.
    Yang, S.
    Chun, C-H
    Chun, J-S
    CELL DEATH AND DIFFERENTIATION, 2012, 19 (03) : 440 - 450
  • [27] LncRNA HOTAIR suppresses TNF-α induced apoptosis of nucleus pulposus cells by regulating miR-34a/Bcl-2 axis
    Yu, Yang
    Zhang, Xianzuo
    Li, Zhongqi
    Kong, Lei
    Huang, Yan
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 107 : 729 - 737
  • [28] miR-181a promotes apoptosis in contusion spinal cord injury rats through targeting Bcl-2
    Li, Xiaobin
    Liu, Tao
    Fan, Lei
    Cai, Teng
    Peng, Qiang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (02): : 2773 - 2781
  • [29] Fas (APO-1/CD95)-mediated apoptosis is independent of bcl-2: A study with cell lines overexpressing bcl-2 and with bcl-2 transfected cell limes
    Gazitt, Y
    Hu, WX
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 12 (01) : 211 - 220
  • [30] miR-34a/BCL-2 signaling axis contributes to apoptosis in MPP+-induced SH-SY5Y cells
    Shanesazzade, Zahra
    Peymani, Maryam
    Ghaedi, Kamran
    Hossein, Mohammad
    Esfahani, Nasr
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2018, 6 (06): : 975 - 981